Stockholders' Equity (Details Textual) (USD $) In Millions, except Share data, unless otherwise specified	1 Months Ended		12 Months Ended				12 Months Ended								1 Months Ended
	May 31, 2008	May 31, 2007	Jun. 30, 2012	Jul. 02, 2011	Jul. 03, 2010	Apr. 27, 2012	Jun. 30, 2012 Class A [Member]	Jul. 02, 2011 Class A [Member]	Jul. 03, 2010 Class A [Member]	Jul. 03, 2010 Maximum [Member]	Jun. 30, 2012 Stock Options [Member]	Jun. 30, 2012 Stock Options [Member] Maximum [Member]	Jun. 30, 2012 Stock Options [Member] Minimum [Member]	Jun. 30, 2012 Restricted Stock Plan [Member]	Nov. 30, 2010 Restated Plan [Member]	Nov. 04, 2010 Restated Plan [Member]	Nov. 04, 2010 2006 Plan [Member]
Stockholders Equity (Textual) [Abstract]
Authorized share repurchase program	$ 175.0	$ 100.0	$ 175.0
Remaining share authorized			57.9
Exercise periods for stock options												10 years	1 year
Unrecognized compensation expense related to non-vested share-based compensation arrangements			7.7
Total intrinsic value of stock options exercised			0.7	0.2						0.1
Stockholders Equity (Additional Textual) [Abstract]
Total number of authorized shares																3,000,000	2,000,000
Total number of additional authorized shares															1,000,000
Repurchase of shares under the share repurchase program							0	0	0
Number of shares granted under plan can be stock appreciation rights, restricted stock, restricted stock units, deferred stock units or stock															1,000,000
Number of equity awards available for grant			1,219,159
Vesting period of stock grants to employees											3 years			5 years
Special cash dividend						$ 6.00
Additional share-based payment expense related to plan amendment			2.1
Remaining share-based compensation expense to be recognized related to plan amendment			0.7
Total income tax benefit recognized			2.1	1.4	1.5
Share-based compensation expense			6.0	4.2	4.5
Weighted-average fair value of stock options on the date of grant			$ 6.10	$ 3.81	$ 4.82
Total cash as a result of the exercise of stock options			2.8	0.6	0.3
Weighted-average period expected term														2 years 8 months 12 days
Total fair value of restricted shares vested			$ 3.1	$ 2.5	$ 2.5